Tempus AI
Analyzing molecular, pathology and clinical data to find therapeutic targets and biomarkers.
Patient-driven research and resources for the angiosarcoma community
We support patients and families, fund targeted research, and share open data to accelerate progress against one of the rarest and most aggressive cancers.
IRS-approved 501(c)(3) public charity Founded by angiosarcoma patients
Just diagnosed? Get evaluated at a high-volume sarcoma center.
Angiosarcoma does not behave like many other cancers. Patients often say they wish they had known early how much experienced care matters.
Where would you like to start?
Two paths, built around what patients and researchers told us they needed most.
For patients and families
Practical guidance for the weeks after a diagnosis and beyond.
- Experienced sarcoma centers
- Clinical trial guidance
- Help paying for second opinions
- A peer support community
For researchers and clinicians
Open data, published work and funding for angiosarcoma-specific science.
- Open molecular dataset (274 patients)
- Published studies
- Grant funding and inquiries
- Full grant history
Too rare to be anyone’s priority. So patients made it theirs.
Angiosarcoma accounts for a tiny fraction of adult cancers. Without a patient-driven effort, it would never be the focus of large-scale science. That is the gap we fill.
Sources: 5-year survival, Cleveland Clinic (opens in a new tab); share of cancers, Sarcoma UK (opens in a new tab).
27%
five-year overall survival rate
<0.1%
of all adult cancers
Where your support goes
Recent grants funded by donors like you.
Washington University
Dr. Brian VanTine is studying surface protein expression on angiosarcoma.
Memorial Sloan Kettering
Travel support so patients can take part in a clinical trial.
Fund the next grant
Pick an amount and give in under a minute. Every gift goes to angiosarcoma-specific research.
Founded by patients, for patients
Lauren Ryan and Corrie Painter started Angiosarcoma Awareness while both were battling primary angiosarcoma of the breast. Lauren passed away on June 19, 2014. We continue the mission in her honor.
We identify laboratories doing angiosarcoma research and raise funds to support their work, revealing the molecular underpinnings that could tailor treatment to each patient.
Read our storyYou are not alone
The Angiosarcoma Cancer group on Facebook is the most active peer community for patients and caregivers. Ask questions, share experiences and find people who understand.
Join the support group (opens in a new tab)Help keep this research going
Your donation directly funds angiosarcoma-specific research and shared resources that benefit patients worldwide.